Doxorubicin Recruiting Phase 2 Trials for BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02978495Neoadjuvant Carboplatin in Triple Negative Breast Cancer